Critical Care Alert – July 1, 2020
July 1, 2020
View Archives Issues
A relatively new modality, high-flow nasal cannula oxygen therapy is used commonly to treat acute respiratory failure.
A multicenter, randomized clinical trial of 641 adults deemed ready for weaning after at least 24 hours of mechanical ventilation revealed that the use of high-flow nasal oxygen (HFNO) with noninvasive ventilation immediately after extubation significantly decreased the risk of reintubation compared to HFNO alone in mechanically ventilated patients who were at high risk of extubation failure.